To Evaluate the Safety and Tolerability of SYHX2001 in Patients With Advanced or Metastatic Solid Tumors

NCT05407909 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

176

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced or Metastatic Solid Tumors

Interventions

DRUG: SYHX2001

Sponsor

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.